Correction: The Role of Ultrasound-Determined Gestational Sac Triple Product

Background

The ultrasound-derived gestational sac triple product has been identified as a potential marker for assessing the likelihood of failure in early medical abortion using mifepristone and misoprostol. Accurate reporting of study ethics is essential for maintaining research integrity.

Data Highlights

No numerical or trial data is presented in the correction article.

Key Findings

• The ethics statement in the original article was incorrect and has been updated.
• The study adhered to the Declaration of Helsinki.
• The Human Research Ethics Committee of Karamay Central Hospital approved the study.
• The need for informed consent was waived by the Committee.
• The corrected review board number is YL-2025-120, issued on November 24, 2025.

Clinical Implications

Clinicians should be aware of the importance of accurate ethical reporting in research studies. This correction emphasizes the need for transparency in the approval processes for studies involving medical abortion.

Conclusion

The correction of the ethics statement reinforces the commitment to ethical standards in medical research. Accurate documentation is vital for the credibility of clinical studies.

Related Resources & Content

1. Xue, R.-H., et al., Front. Med., 2026 -- Ultrasound-derived gestational sac triple product as a predictor of early medical abortion failure
2. Archives of Gynecology and Obstetrics — Transvaginal ultrasonographic characteristics of different types of residual pregnancy tissue in patients with incomplete medication abortion
3. Frontiers in Endocrinology — Predictive value of routine ultrasound indicators in the second trimester for gestational diabetes mellitus: a retrospective cohort study
4. BMC Pregnancy and Childbirth — Correction: The predictive value of uterine artery doppler in the success rate of pregnancy from the first frozen embryo transfer during the implantation window
5. Frontiers in Endocrinology — Association between urinary hCG trajectories and the risk of miscarriage in women undergoing embryo transfer: a prospective cohort study
6. WHO Abortion Care Guideline, 2nd ed
7. Ultrasound-derived gestational sac triple product as a predictor of early medical abortion failure with mifepristone-misoprostol regimens: a retrospective cohort study
8. Randomized Trial of Very Early Medication Abortion | New England Journal of Medicine